Hypera S.A. (ADR)
General ticker "HYPMY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $2.5B (TTM average)
Hypera S.A. (ADR) follows the US Stock Market performance with the rate: 33.2%.
Estimated limits based on current volatility of 2.9%: low 4.32$, high 4.59$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-10-06, amount 0.04$ (Y3.64%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.87$, 4.14$]
- 2025-12-31 to 2026-12-31 estimated range: [1.82$, 3.90$]
Financial Metrics affecting the HYPMY estimates:
- Positive: with PPE of 7.3 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 24.13 > 18.64
- Positive: Operating cash flow per share per price, % of 22.45 > 13.24
- Negative: negative Industry operating cash flow (median)
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 5.18
- Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15
- Positive: -14.38 < Investing cash flow per share per price, % of -5.24
Short-term HYPMY quotes
Long-term HYPMY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | BRL7,546.35MM | BRL7,914.66MM | BRL7,442.47MM |
| Operating Expenses | BRL4,903.72MM | BRL5,629.41MM | BRL5,646.70MM |
| Operating Income | BRL2,642.63MM | BRL2,285.25MM | BRL1,795.77MM |
| Non-Operating Income | BRL-1,031.53MM | BRL-775.77MM | BRL-816.53MM |
| Interest Expense | BRL986.08MM | BRL1,349.52MM | BRL971.05MM |
| R&D Expense | BRL159.39MM | BRL189.76MM | BRL145.53MM |
| Income(Loss) | BRL1,611.10MM | BRL1,509.47MM | BRL979.24MM |
| Taxes | BRL-95.35MM | BRL-141.64MM | BRL-353.76MM |
| Profit(Loss)* | BRL1,696.70MM | BRL1,647.96MM | BRL1,340.99MM |
| Stockholders Equity | BRL10,645.76MM | BRL11,504.12MM | BRL12,096.28MM |
| Inventory | BRL2,195.98MM | BRL2,191.73MM | BRL1,938.60MM |
| Assets | BRL23,755.63MM | BRL24,508.75MM | BRL24,559.08MM |
| Operating Cash Flow | BRL2,038.79MM | BRL2,395.99MM | BRL2,539.60MM |
| Capital expenditure | BRL1,509.46MM | BRL812.71MM | BRL772.27MM |
| Investing Cash Flow | BRL-1,742.34MM | BRL-791.19MM | BRL-592.44MM |
| Financing Cash Flow | BRL278.95MM | BRL-1,886.38MM | BRL-2,788.73MM |
| Earnings Per Share** | BRL2.68 | BRL2.58 | BRL2.12 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.